HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Zhang Selected Research

Rheumatoid Arthritis

11/2020Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity.
8/2019MiR-21 relieves rheumatoid arthritis in rats via targeting Wnt signaling pathway.
11/2018Correlation between rheumatoid arthritis and immunological changes in a rheumatoid arthritis rat model.
1/2018LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-α stimulation.
2/2015Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis.
1/2014The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritis.
1/2014An updated meta-analysis of the signal transducer and activator of transcription 4 (STAT4) rs7574865 G/T polymorphism and rheumatoid arthritis risk in an Asian population.
1/2013Vascular endothelial growth factor A (VEGFA) polymorphisms in Chinese patients with rheumatoid arthritis.
1/2013MSRA polymorphism is associated with the risk of rheumatoid arthritis in a Chinese population.
8/2012Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Zhang Research Topics

Disease

390Neoplasms (Cancer)
12/2022 - 01/2000
103Infections
06/2022 - 02/2000
78Breast Neoplasms (Breast Cancer)
06/2022 - 01/2000
74Neoplasm Metastasis (Metastasis)
03/2022 - 01/2000
74Inflammation (Inflammations)
01/2022 - 04/2000
47Carcinogenesis
11/2021 - 06/2000
43Hypertension (High Blood Pressure)
08/2021 - 04/2000
43Hypoxia (Hypoxemia)
01/2021 - 04/2000
42Fibrosis (Cirrhosis)
08/2022 - 03/2001
41Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2000
41Body Weight (Weight, Body)
01/2022 - 11/2000
41Carcinoma (Carcinomatosis)
12/2020 - 01/2000
40Pain (Aches)
01/2022 - 08/2000
37Necrosis
06/2022 - 12/2000
37Wounds and Injuries (Trauma)
06/2022 - 06/2000
35Stomach Neoplasms (Stomach Cancer)
12/2021 - 07/2001
34Lung Neoplasms (Lung Cancer)
07/2022 - 12/2000
34Hemorrhage
05/2022 - 01/2000
31Myocardial Infarction
05/2022 - 04/2000
31Obesity
11/2020 - 10/2000
30Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 06/2001
29Stroke (Strokes)
05/2022 - 05/2000
29Ischemia
12/2020 - 06/2000
27Insulin Resistance
11/2022 - 06/2005
27Thrombosis (Thrombus)
12/2020 - 11/2000
26Prostatic Neoplasms (Prostate Cancer)
01/2021 - 03/2000
25Type 2 Diabetes Mellitus (MODY)
05/2022 - 09/2000
25Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2021 - 06/2000
24Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 07/2001
24Leukemia
11/2020 - 01/2001
22Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 07/2000
22Reperfusion Injury
08/2021 - 06/2000
21Asthma (Bronchial Asthma)
05/2022 - 07/2000
20Osteoarthritis
11/2022 - 02/2007
20Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2000
20Alzheimer Disease (Alzheimer's Disease)
01/2017 - 11/2000
19Tuberculosis (Tuberculoses)
09/2018 - 03/2000
17Disease Progression
05/2022 - 11/2001
17Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021 - 03/2012
17Heart Failure
05/2021 - 04/2000
17Pre-Eclampsia (Preeclampsia)
11/2020 - 05/2000
17Rheumatoid Arthritis
11/2020 - 10/2000
17Infarction (Infarctions)
06/2019 - 02/2000
17Hypersensitivity (Allergy)
01/2019 - 06/2000
16Pneumonia (Pneumonitis)
06/2022 - 08/2000
16Lymphoma (Lymphomas)
04/2022 - 01/2001
16Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 11/2001
15Diabetes Mellitus
05/2022 - 05/2006
15Brain Ischemia (Cerebral Ischemia)
01/2022 - 12/2000
15Melanoma (Melanoma, Malignant)
11/2021 - 03/2000
14Atherosclerosis
11/2021 - 06/2001

Drug/Important Bio-Agent (IBA)

220Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2000
98Messenger RNA (mRNA)IBA
07/2022 - 01/2000
66CytokinesIBA
07/2022 - 02/2000
61Pharmaceutical PreparationsIBA
07/2022 - 03/2000
60MicroRNAs (MicroRNA)IBA
01/2022 - 03/2009
52Glucose (Dextrose)FDA LinkGeneric
11/2022 - 02/2000
48Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2004
46Long Noncoding RNAIBA
05/2022 - 03/2014
39Biological ProductsIBA
03/2022 - 06/2000
37DNA (Deoxyribonucleic Acid)IBA
08/2020 - 01/2000
32Insulin (Novolin)FDA Link
07/2022 - 02/2000
32EnzymesIBA
11/2021 - 12/2000
31Therapeutic UsesIBA
06/2021 - 03/2001
29RNA (Ribonucleic Acid)IBA
01/2022 - 01/2000
28Interleukin-6 (Interleukin 6)IBA
06/2022 - 11/2001
28AntigensIBA
03/2022 - 03/2000
28Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2001
27VaccinesIBA
05/2022 - 04/2001
24Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 12/2000
24CollagenIBA
11/2021 - 01/2000
21Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2000
21LipidsIBA
11/2021 - 04/2000
20salicylhydroxamic acid (SHAM)IBA
06/2022 - 04/2000
20Immunoglobulin G (IgG)IBA
06/2022 - 01/2000
20Small Interfering RNA (siRNA)IBA
03/2022 - 01/2004
20Phosphotransferases (Kinase)IBA
08/2021 - 10/2000
19C-Reactive ProteinIBA
06/2022 - 11/2006
18Hormones (Hormone)IBA
04/2022 - 04/2000
18LigandsIBA
08/2021 - 02/2000
18Cisplatin (Platino)FDA LinkGeneric
02/2021 - 06/2001
17Indicators and Reagents (Reagents)IBA
07/2021 - 03/2000
17Peptides (Polypeptides)IBA
07/2020 - 10/2000
17AntibodiesIBA
10/2019 - 04/2001
15Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 09/2000
15Oxygen (Dioxygen)IBA
03/2022 - 03/2000
15CholesterolIBA
01/2021 - 03/2000
15NF-kappa B (NF-kB)IBA
07/2019 - 05/2000
15Adenosine Triphosphate (ATP)IBA
01/2018 - 06/2001
14AutoantibodiesIBA
02/2022 - 01/2000
14ErbB Receptors (EGF Receptor)IBA
02/2022 - 01/2000

Therapy/Procedure

182Therapeutics
05/2022 - 03/2000
69Drug Therapy (Chemotherapy)
04/2022 - 01/2000
31Aftercare (After-Treatment)
03/2022 - 01/2000
29Radiotherapy
11/2021 - 01/2000
25Transplantation
04/2022 - 08/2000
25Stents
01/2022 - 04/2001
19Percutaneous Coronary Intervention
05/2022 - 05/2015
19Hematopoietic Stem Cell Transplantation
01/2022 - 08/2005
15Ligation
06/2022 - 04/2000